These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 65583)

  • 21. Letter: Thromboembolism, oral contraceptives, and oestrogen concentration gradient.
    Mueller H; Stadel BV
    Lancet; 1975 Mar; 1(7908):683-4. PubMed ID: 47105
    [No Abstract]   [Full Text] [Related]  

  • 22. Paroxetine may increase risk for congenital malformations.
    Cuzzell JZ
    Dermatol Nurs; 2006 Feb; 18(1):68. PubMed ID: 16617525
    [No Abstract]   [Full Text] [Related]  

  • 23. Benzodiazepine exposure in pregnancy and risk of major malformations: a critical overview.
    Bellantuono C; Tofani S; Di Sciascio G; Santone G
    Gen Hosp Psychiatry; 2013; 35(1):3-8. PubMed ID: 23044244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic drugs in pregnancy. Caution is the watchword.
    Niebyl JR
    Postgrad Med; 1984 Jun; 75(8):165-6, 169-72. PubMed ID: 6728734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Contraception and arterial hypertension].
    Corvol P; Millet D; Keledjian P
    Acquis Med Recent; 1977; ():177-80. PubMed ID: 910596
    [No Abstract]   [Full Text] [Related]  

  • 26. Development of hepatoma in rats following oral administration of synthetic estrogen and progestogen.
    Higashi S; Tomita T; Mizumoto R; Nakakuki K
    Gan; 1980 Aug; 71(4):576-7. PubMed ID: 7429093
    [No Abstract]   [Full Text] [Related]  

  • 27. Multiple congenital anomalies in a fetus exposed to 5-fluorouracil during the first trimester.
    Stephens JD; Golbus MS; Miller TR; Wilber RR; Epstein CJ
    Am J Obstet Gynecol; 1980 Jul; 137(6):747-9. PubMed ID: 7395946
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effects of estrogen-progestin therapy on the periodontium. A review of the literature].
    Nicolò M; Crea D; Lauriello C
    Minerva Stomatol; 1986 Sep; 35(9):845-7. PubMed ID: 3466011
    [No Abstract]   [Full Text] [Related]  

  • 29. Editorial: Another possible teratogen?
    Archer JD
    JAMA; 1975 Jan; 231(1):69. PubMed ID: 1243572
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of oral hormone replacement therapy on liver function tests.
    Moore B; Paterson M; Sturdee D
    Maturitas; 1987 Apr; 9(1):7-15. PubMed ID: 3600424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [What to do in practice when confronted with hyperlipemia?].
    Decoulx M
    Lille Med; 1975 Apr; 20(4):370-3. PubMed ID: 1152587
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hormone therapy and the risk of cancer in the climacteric].
    Kuhl H; Taubert HD
    Gynakologe; 1986 Dec; 19(4):259-65. PubMed ID: 3817599
    [No Abstract]   [Full Text] [Related]  

  • 33. Birth defects after exposure to misoprostol in the first trimester of pregnancy: prospective follow-up study.
    Vauzelle C; Beghin D; Cournot MP; Elefant E
    Reprod Toxicol; 2013 Apr; 36():98-103. PubMed ID: 23207166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study.
    Bar-Oz B; Diav-Citrin O; Shechtman S; Tellem R; Arnon J; Francetic I; Berkovitch M; Ornoy A
    Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):31-4. PubMed ID: 18760873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thromboembolism and synthetic estroprogestational hormones. Apropos of 2 cases].
    Boespflug O
    Phlebologie; 1975; 28(3-4):373-4. PubMed ID: 1230800
    [No Abstract]   [Full Text] [Related]  

  • 36. [Possible interference of synthetic estroprogestins with thyroid hormone production].
    Paggi A; Leri O; Evangelista M; Manfredi F; Coarelli C; Loiacono C; Cassone R
    Clin Ter; 1981 Aug; 98(4):349-63. PubMed ID: 7285541
    [No Abstract]   [Full Text] [Related]  

  • 37. [Syndrome due to estrogen-progestogens in a worker engaged in the production of contraceptive agents].
    Gambini G; Farina G; Arbosti G
    Med Lav; 1976; 67(2):152-7. PubMed ID: 1021708
    [No Abstract]   [Full Text] [Related]  

  • 38. Teratogenicity of minor tranquilizers.
    Behav Neuropsychiatry; 1975 Apr-1976 Mar; 7(1-12):4-5. PubMed ID: 9056
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hormone substitution by injectable preparations and skin implants].
    Kuhl H
    Gynakologe; 1986 Dec; 19(4):241-7. PubMed ID: 3817596
    [No Abstract]   [Full Text] [Related]  

  • 40. [Synthetic female hormones-induced liver cancer].
    Azuma T; Mizumoto R
    Gan No Rinsho; 1989 May; Spec No():54-61. PubMed ID: 2557462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.